Comparative expression analysis of phospholipid binding protein annexina1 in nephrogenesis and kidney cancer

Roshni Sadashiv, Balappa Murgappa Bannur, Praveenkumar Shetty, Udupi Shastry Dinesh, Jamboor K.vishwanatha, Subhash Krishnarao Deshpande, Anil Bargale, E. Sarathkumar, Komal Ruikar

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The expression in the glomerular mesangial cells, papillary, and collecting duct cells demonstrated annexin A1 (AnxA1)'s role in specific renal functions. With varying concentrations of calcium (Ca2+), it is considered to regulate cellular processes such as cell proliferation, apoptosis, and clearance of apoptotic cells by forming ceramides, a key lipid mediator of apoptosis. It also participates in tumorigenesis based on its location. On account of these features, we investigated the expression of this apoptosis-associated protein in fetal kidneys at different gestational periods, mature kidneys and in kidney cancer tissues in order to localize and possibly characterize its role during nephrogenesis and renal tumors. AnxA1 expression was evaluated by an immunohistochemistry technique in "paraffin-embedded"renal tissue sections from autopsied fetuses at different gestational ages, in mature kidneys and renal cancer tissues. The current study data demonstrated that AnxA1 is expressed in the mesangial cells and podocytes of maturing glomeruli in the developing renal cortex of fetal kidneys at 14 to 19 weeks of gestation. The expression in the mesangial cells declined in later weeks of gestation and persisted into adulthood. AnxA1 expression increased with the progression of clear cell renal cell carcinoma (CCRCC) and also in other cancer types indicating a potential role of the protein in tumorigenesis. We presume that AnxA1 in the podocytes and mesangial cells play important roles in various signaling pathways in the functioning of the glomerulus. These results and concepts provide a framework to further dissect its biological properties and thereby develop diagnostic, prognostic, and therapeutic strategies targeting the molecule in various renal pathologies.

Original languageEnglish
Article number20190179
JournalJournal of Basic and Clinical Physiology and Pharmacology
Issue number4
StatePublished - 1 Jul 2020


  • annexinA1
  • fetal kidney
  • nephrogenesis marker
  • phospholipid binding protein
  • renal cell carcinoma


Dive into the research topics of 'Comparative expression analysis of phospholipid binding protein annexina1 in nephrogenesis and kidney cancer'. Together they form a unique fingerprint.

Cite this